Lung Denervation System Named Breakthrough Therapy by FDA

The Nuvaira Lung Denervation System has been designated as a Breakthrough Device by the US FDA. Nuvaira's lung denervation system is a bronchoscopic procedure designed to reduce the risk of moderate-to-severe COPD exacerbations.